New York, New York — November 20, 2025 — Leads & Copy — Intelligent Bio Solutions Inc. (NASDAQ: INBS) will participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2-3, 2025, in Boca Raton, Florida, according to a company announcement.
The conference will be held at Florida Atlantic University, Boca Raton, FL. INBS’s presentation is scheduled for Wednesday, December 3, 2025, at 11:00 a.m. Eastern Time in Presentation Room 2.
A webcast recording of Intelligent Bio Solutions’ presentation will be available the following day on the company’s investor relations website, Noble’s website, and Channelchek, for 90 days after the event. Investors interested in attending can register using the discount code INBSNOBLECON.
For further details about the conference or to arrange a one-on-one meeting with the Intelligent Bio Solutions management team, individuals should contact their Noble Capital Markets representative or email KCSA Strategic Communications at INBS@ksca.com.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) delivers rapid, non-invasive testing solutions. The company’s Intelligent Fingerprinting Drug Screening System utilizes fingerprint sweat analysis for portable testing and screens for recent drug use, including opiates, cocaine, methamphetamine, and cannabis. Sample collection takes seconds, with results available in under ten minutes. Customer segments include construction, manufacturing, engineering, transport, logistics, mining, drug treatment organizations, and coroners.
Valter Pinto, Managing Director of KCSA Strategic Communications can be contacted at (212) 896-1254 or INBS@kcsa.com.
Source: Intelligent Bio Solutions Inc.
Source: Intelligent Bio Solutions Inc.
